Sean MacLeod is listed as an executive officer and director on 2 SEC Form D filings by 1 issuer between Feb 2026 and Oct 2026: CytoTerra Inc. (Seattle, WA — other technology — 2026; $1.02M reported sold to 13 investors).
What this means One deal on file with the SEC, filed Oct 2026. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Jesse Salk (2 shared filings), Stephen Eacker (2 shared filings) and Kenneth Horenstein (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Sean. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Sean MacLeod and found 1 difference: Sean MacLeod's role changed at CytoTerra Inc.: director → executive officer.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.